Tag Archives: Panel

Screen All Adult Patients for Drug Abuse, National Panel Urges

A national panel of health experts recommended on Tuesday that doctors screen all adult patients for illicit drug use, including improper use of prescription medications. But the group, the United States Preventive Services Task Force, stopped short of endorsing such screening for teenagers, a position that puts them at odds with major adolescent health groups.… Read More »

Opioid for Depression Comes Before FDA Panel

An investigational drug that targets the opioid system for major depressive disorder will be reviewed in an FDA advisory committee meeting Thursday, and briefing documents from agency staff suggest the product won’t have an easy time. The safety and efficacy of ALKS 5461, a combination of buprenorphine and samidorphan intended to be used as adjunctive… Read More »